Doctor of Medical Sciences
H-index: RSCI 10, Scopus 5, Web of Science 5
Articles
-
Kamenshchikov N.O., Podoksenov Yu.K., Anfinogenova Y.J., Kozlov B.N., Svirko Yu.S., Pekarskiy S.E., Evtushenko V.V., Lugovsky V.A., Shipulin V.M., Lomivorotov V.V. Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. The Journal of Thoracic and Cardiovascular Surgery 2022;163(4):1 393-1 403.
-
Pekarskiy S.E., Baev A.E., Falkovskaya A.Yu., Lichikaki V.A., Sitkova E.S., Zubanova I.V., Manukyan M.A., Tarasov M.G., Mordovin V.F., Popov S.V. Durable strong efficacy and favorable long-term renal safety of the anatomically optimized distal renal denervation according to the 3 year follow-up extension of the double-blind randomized controlled trial. Heliyon 2022;8(1):1-6.
-
Bhatt D.L., Steg P.G., Miller M., Brinton E.A., Jacobson T.A., Ketchum S.B., Doyle Jr R.T., Juliano R.A., Jiao L., Granowitz C., Tardif J.C., Ballantyne C.M., Mordovin Viktor, Falkovskaya Alla, Ripp Tatiana, Triss Sergei, Pekarskiy Stanislav, Sitkova Ekaterina Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine 2019;380(1):11-22.
-
Pekarskiy S.E., Baev A.E., Mordovin V.F., Semke G.V., Ripp T.M., Falkovskaya A.U., Lichikaki V., Sitkova E.S., Zubanova I.V., Popov S. Denervation of the distal renal arterial branches versus conventional main renal artery treatment: a randomised controlled trial for treatment of resistant hypertension. Journal of Hypertension 2017;35(2):369-375.
-
Davies J., Pekarskiy S. Promising studies on renal denervation in the entire length of the main artery, as well as treatable branches, including accessories. Confluence (Concepts and opinions in interventional cardiovascular medicine). 2017; :22-26.
-
Ripp T.M., Mordovin V.F., Pekarskiy S.E., Ryabova T.R., Zlobina M.V., Baev A.E., Anfinogenova Y., Popov S.V. Predictors of renal denervation efficacy in the treatment of resistant hypertension. Current Hypertension Reports 2015;17(12):1-7.